Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Controlled release of multiple drugs for sequential combination therapy remains a significant challenge in advanced drug delivery.
• Developing smart nanocomposites with precise spatiotemporal drug release is crucial for enhancing therapeutic efficacy.

Purpose of the Study:

• To create a novel drug delivery nanocomposite for sequential combination cancer therapy.
• To achieve precise control over the release kinetics of two anticancer drugs, doxorubicin (DOX) and paclitaxel (PTX).

Main Methods:

• Coating porous silicon (PSi) nanoparticles with poly(beta-amino ester) (PAE) and Pluronic F-127.
• Loading DOX into the PSi core and PTX into the F127 shell.
• Investigating the spatiotemporal drug release profiles and in vitro cytotoxicity.

Main Results:

• The developed nanocomposite demonstrated enhanced colloidal stability and cytocompatibility.
• A time-staggered release of PTX (faster, earlier) and DOX (slower, later) was achieved at pH 7.0.
• The poly(beta-amino ester) (PAE) layer functioned as a pH-responsive nanovalve for site-specific DOX release.
• Co-loaded nanoparticles showed a superior synergistic cytotoxic effect compared to free drugs, inducing significant cellular apoptosis.

Conclusions:

• This study presents a promising strategy for enhancing combination cancer therapies.
• Precise control over drug release kinetics using smart nanocomposites can significantly improve therapeutic outcomes.
• The developed PSi-based nanocomposite offers a viable platform for sequential combination drug delivery.